share_log

信立泰(002294.SZ):预计未来每年将有1-2个新产品上市

Shenzhen Salubris Pharmaceuticals (002294.SZ): It is expected that 1 to 2 new products will be launched each year in the future.

Gelonghui Finance ·  Dec 13 15:29

Gelonghui, December 13 | Xinlitai (002294.SZ) said at a recent investor relations event that the company is deeply involved in the field of chronic diseases, with cardiovascular and cerebrovascular diseases as the core, and is expanding in the fields of nephrology, orthopedics, metabolism, self-immunity, etc. The company currently has 4 new drugs on the market, mainly hypertension, nephrology, and diabetes. It is expected that 1-2 new products will be launched every year in the future. As society ages, the demand in these fields will also be huge. The company's products also have characteristics, and I believe there are good expectations.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment